That opens the door for broader access to Zepbound, which is not currently covered ... approved by the Food and Drug Administration, the CMS spokesperson said, referring to the agency's guidance.

In fact, in March 2024, with the introduction of new and popular AOMs (e.g., Ozempic, Wegovy, and Zepbound), CMS issued guidance confirming that “all drugs used for weight loss have been ...

The news also opens the door for Zepbound to be covered by federal health insurance in the United States. In March, the U.S.Centers for Medicare and Medicaid Services (CMS) issued new guidance ...

The FDA has approved Zepbound (tirzepatide) for treating moderate to severe obstructive sleep apnea (OSA) in adults with obesity. The drug, coupled with a calorie-deficit diet and increased ...

Eli Lilly has partnered with the telehealth company Ro to expand access to single-dose vials of its popular weight loss drug Zepbound. Through Ro's platform, eligible patients can receive ...

Some of the most prominent GLP-1 drugs, also known as drugs used for weight loss, include Ozempic, Wegovy, Mounjaro and Zepbound ... under RFK Jr. as head of the CMS. Oz has spoken favorably ...

Obesity is a major global health crisis, especially in the United States, but newer weight-loss drugs like Eli Lilly’s (LLY) Zepbound could offer a long-awaited solution — if they become more ...